Yatharth Hospital & Trauma Care Services Ltd posted record revenue of Rs 3,927 million in Q1FY27, a 51% jump year-on-year. The company also announced its first interim dividend of 5% and showed strong operational momentum, with new hospitals contributing significantly.
Yatharth Hospital & Trauma Care Services Ltd - Q1FY27 Financial Update
Revenue: Rs 3,927 Mn (51% YoY Growth)
PAT: Rs 454 Mn (8% YoY Growth)
Reader Takeaway: Record revenue and PAT growth driven by new hospital additions; maiden dividend declared.
What just happened
Yatharth Hospital & Trauma Care Services Ltd announced its first-quarter results for FY27, reporting a record revenue of Rs 3,927 million, up 51% from Rs 2,592 million in Q1FY26. EBITDA grew 39% to Rs 917 million. Profit After Tax (PAT) saw an 8% increase to Rs 454 million from Rs 420 million year-on-year. The company also declared a maiden interim dividend of 5% on face value.
Why this matters
The strong revenue growth, exceeding 50%, indicates successful expansion and operational efficiency. The maiden dividend signifies a commitment to shareholder returns. The performance of new hospitals, contributing 27% of revenue, highlights the company's ability to scale its business effectively, even with initial ramp-up costs impacting margins.
The backstory
Founded in 2008, Yatharth Hospital is a multi-specialty healthcare provider primarily operating in North India. The company has been on an expansion spree, acquiring and building new facilities to broaden its network and patient reach. This quarter's results reflect the payoff from these strategic investments.
What changes now
The company's growth trajectory appears strong, supported by increased capacity and operational improvements. The focus now shifts to how efficiently the new facilities will contribute to profitability and margin expansion as they mature. The dividend payout suggests growing confidence in sustained performance.
Risks to watch
The reported EBITDA margin dipped by 209 basis points year-on-year to 23.3%. This was due to ramp-up losses from new assets like Faridabad Sector-20 and New Delhi. Investors will be watching closely to see how quickly these newer units achieve breakeven and contribute positively to overall margins.
Peer comparison
While specific peer results for the same quarter were not provided in the filing, the healthcare sector in India has seen significant growth post-pandemic. Competitors like Apollo Hospitals, Fortis Healthcare, and Max Healthcare also focus on capacity expansion and service quality. Yatharth's performance, especially the rapid scaling of new facilities and breakeven timelines, will be a key differentiator.
Context metrics (time-bound)
- Revenue Growth: 51% YoY (Q1FY27 vs Q1FY26), 15% QoQ (Q1FY27 vs Q4FY26).
- EBITDA Growth: 39% YoY, 15% QoQ.
- PAT Growth: 8% YoY, 2% QoQ.
- New Hospitals Contribution: 27% of total revenue (Rs 1,067 Mn).
- Faridabad Sector-20: Achieved EBITDA breakeven within nine months.
- Agra Hospital: Delivered EBITDA margin over 20% in its first full quarter.
- Group ARPOB: Rs 34,758 (up 7% YoY).
What to track next
Investors will be keen to monitor the margin performance of new hospitals, the continued growth in ARPOB, and further updates on capacity utilization across the network. The successful integration and profitability of acquired and built facilities remain a key focus.
